InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Schelling Chris. Director active across 1 company, notably Acer Therapeutics Inc.. In total, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €967k. Activity tracked since 29 November 2022. The latest transaction was disclosed on 29 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations